IVBT (Innovation1 Biotech) EPS (Basic): $-0.30 (TTM As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech EPS (Basic)?

Innovation1 Biotech IVBT 12 EPS (Basic) is $-0.30 as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's basic earnings per share (Basic EPS) for the three months ended in Feb. 2024 was $-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.30.

Innovation1 Biotech's EPS (Diluted) for the three months ended in Feb. 2024 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.30.

Innovation1 Biotech's EPS without NRI for the three months ended in Feb. 2024 was $-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2024 was -0.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Innovation1 Biotech  (OTCPK:IVBT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Innovation1 Biotech EPS (Basic) Related Terms

Innovation1 Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech EPS (Basic) Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -0.39 -8.59 5.53 -2.73 -0.70

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 -0.03 -0.23 -0.02 -0.02
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Innovation1 Biotech's Basic EPS for the fiscal year that ended in Aug. 2023 is calculated as

Basic EPS (A: Aug. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.988-8.091)/20.184
=-0.70

Innovation1 Biotech's Basic EPS for the quarter that ended in Feb. 2024 is calculated as

Basic EPS (Q: Feb. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.29-0.234)/22.470
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.30 mean?
Innovation1 Biotech (IVBT) has a EPS (Basic) of $-0.30 as of Feb. 2024. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's EPS (Basic) too high?
Innovation1 Biotech's current EPS (Basic) is $-0.30. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's EPS (Basic) compare to NVIV and PXMD?
Innovation1 Biotech's EPS (Basic) of $-0.30 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Diversified Financial Services company?
A good EPS (Basic) depends on the Diversified Financial Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current EPS (Basic) is $-0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current EPS (Basic) of $-0.30. The current EPS (Basic) is $-0.30. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current EPS (Basic) is $-0.30 as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price